CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indonesia
Summary
Indonesian pharmaceutical market increased from US$3.13 Billion in 2009 to US$6.20 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of 10.3%. The market value is expected to reach US$10.11 Billion in 2021. The growth of the Indonesian pharmaceutical sector is largely driven by the Universal Health Coverage scheme (Jaminan Kesehatan Nasional, JKN), which prioritizes the use of generics. Despite increasing sales of unbranded generics, the sector is witnessing a growing number of new players, which drive price competition and reduce margins. In 2015, the unbranded generic market represented a 10.8% of the pharmaceutical market.
In 2015, the pharmaceutical-sales-to-GDP ratio shrank to 0.57%, despite pharmaceutical sales increasing from US$6.18 Billion in the previous year to US$6.89 Billion. Pharmaceutical sales per capita increased from US$24.5 Billion in 2014 to US$26.9 Billion in 2015. The pharmaceutical-sales-to-health-spending ratio dropped from US$21.4 Billion in 2014 to US$20.5 Billion in 2015. Non-communicable diseases cost the economy US$7 Billion between 2011 and 2015 in treatment and loss of productivity.
Medical device market of Indonesia was worth US$2.28 Billion in 2016, and is expected to reach US$2.83 Billion in 2017 and US$3.54 Billion in 2018. Indonesia manufactures hospital beds, disposable supplies and wheelchairs, but imports more than 90% of its medical devices, as the domestic industry is under-developed.
The report “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indonesia” is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Indonesia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Indonesia.
In particular, this report provides the following –
– Provides an overview of the Indonesian pharmaceutical and medical device markets, covering market size; the market shares of generic, Over-the-Counter (OTC) and biologic/biosimilar products; and the key drivers and barriers for the overall market. It also includes profiles of the major players, as well as SWOT assessments.
– Covers the reimbursement and payer landscape, and includes details of the reimbursement process, insurance providers, pricing policies and drug price trends in Indonesia. It also looks at the regulatory landscape, and gives an overview of the regulatory agencies and approval processes for new drugs and medical devices.
– Detailed analysis of the political and economic environment in Indonesia, and analyzes economic indicators, demographics, and healthcare infrastructure and expenditure.
– Provides an overview of the opportunities for and challenges to growth in the Indonesian healthcare market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Indonesia, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market (Kalbe Farma, Tempo Scan, Kimia Farma, DaryaVaria and IndoFarma)
– An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
– Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
– An overview of the opportunities for and challenges to growth in the Indonesian healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to –
– Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
– Identify, understand, and capitalize on the opportunities and challenges in the Indoensian healthcare market.